Antibodies from individuals in South Africa who had recovered from a SARS-CoV-2 infection from the first wave of the epidemic are less effective at neutralising the new...
March 24th, 2021US immunotherapy company ImmunityBio, founded and headed by South African born and educated Dr Patrick Soon-Shiong, will partner with Cape-Town-based Biovac to...
The dominant new variant of the COVID-19 virus in South Africa, 501Y.V2, can escape antibodies generated from previous infection. This means that antibodies from people...Weekly Roundup
Health minister Zweli Mkhize has assured MPs that the government was close to finalising key coronavirus vaccine deals with pharmaceutical manufacturers Johnson &...South Africa
More than half of South Africans probably have already been infected with SARS-CoV-2, with blacks three-to-five times more likely than white people to have antibodies to...
February 17th, 2021The muddled acquisition AstraZeneca vaccine from India, found on delivery to have an April expiry date and not the normal six-month one, continues, writes MedicalBrief....
The new COVID-19 variant identified in South Africa can evade the antibodies that attack it in treatments using blood plasma from previously recovered...
